OPTI: Positive EBITDA achieved in Q3 2025, with strong sales and improved margins year-over-year

About this update from Opticept Technologies Ab

Q3 2025 saw a return to positive EBITDA, driven by strong olive oil segment sales and cost reductions. Revenue and margins improved year-over-year, with new orders and product launches supporting growth. Liquidity remains a focus as expansion continues.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Opticept Technologies Ab